Back to All Articles
Browse articles with tag: Mitochondrial Disease
You must be logged in to create a new article
Axsome Therapeutics and Hetero Labs Settle Patent Dispute Over SUNOSI
Axsome Therapeutics and Hetero Labs Settle Patent Dispute Over SUNOSI
In a significant development for the central nervous system (CNS) therapeutics market, Axsome Therapeutics, Inc. (NASDAQ: AXSM) has reached a... Read More
Featured
All Articles
Raina Pang
Mar 19, 2012
Three parent offspring and targeted RNA offer promise for treating mitochondrial dysfunction
Our cells need energy. The majority of this energy comes from adenosine triphosphate (ATP), which is generated by mitochondria. In... Read More